Navigation Links
Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 18, 2009 to Discuss Fourth Quarter 2008 Results
Date:2/11/2009

WALTHAM, Mass., Feb. 11 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in rapid point-of-care diagnostic products, today announced that it will release its fourth quarter 2008 earnings on Wednesday, February 18, 2009. The Company will also host a conference call beginning at 10:00 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call the Company may discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing 706-679-1656 (domestic and international), an access code is not required, or via a link on the Inverness website at www.invernessmedical.com. It is also available via link at https://event.meetingstream.com/r.htm?e=134985&s=1&k=91C3084D8CBF362549FF6D6A8D9F0BDC using Real Player or Windows Media. An on-demand web cast of the call will be available at the Inverness website (www.invernessmedical.com/News.cfm) two hours after the end of the call and will be accessible for 30 days.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious diseas
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Inverness Completes Acquisition of Cholestech
2. Inverness Medical Innovations Acquires Bio-Stat Healthcare Group
3. Inverness Medical Innovations Acquires Alere Medical
4. Inverness Medical Innovations Announces Closing of Public Offering
5. Inverness Medical Innovations to Participate at 2007 RBC Healthcare Conference on December 12, 2007
6. Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory
7. Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
8. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
9. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 20, 2008 to Discuss Fourth Quarter 2007 Results
10. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Inverness Medical Innovations, Inc. Who Invested in the Inverness Medical Innovations, Inc. Employee Savings Plan
11. Correction: Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Inverness Medical Innovations, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... (PRWEB) May 06, 2015 As ... the HIMSS EMR Adoption Model, the hospital looked ... patient engagement and automate processes. The leadership team ... paper-driven to electronic workflows, patient registration still required ... of consents. With HIMSS Stage 7 attestation fast ...
(Date:5/6/2015)... May 06, 2015 Corporate Executives ... of MEBC, an Alliance Award for excellence in ... FOCUS 2015, JDA’s annual user conference which brought ... and wholesale distribution sectors. This award recognizes MEBC, ... receiving services that advance their supply chain performance ...
(Date:5/6/2015)... The Beryl Institute announces the publication of ... (PXJ), an international, open access, peer-reviewed journal focused on ... experience. The second volume of PXJ supports the goal ... the voices engaged and provides the space for listening, ... The Beryl Institute, Volume 2, Issue 1 includes ...
(Date:5/6/2015)... Marketing Maven announces a ... sanitation and hygiene nonprofit by GuideStar’s Philanthropedia. , “WaterAid ... and it brings our agency great joy to work ... “The ongoing relationship between WaterAid and Marketing ... learn about and support the nonprofit as they aim ...
(Date:5/6/2015)... 06, 2015 Wolters Kluwer , ... and students, announced today that in a survey of ... use of the clinical decision support resource improves the ... of 2014, UpToDate users in more than 170 countries ... month, on average. In Germany alone, 95% of all ...
Breaking Medicine News(10 mins):Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:MEBC Receives Award for Consulting Excellence in Retail 2Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3
... Dining Out For Life ... A night of food ... Every year since 1991, ActionAIDS has shown their ... and their philanthropy have made a very real difference ... with HIV and AIDS. ActionAIDS recognizes those individuals with ...
... The managing director of Publication CONNEXION, a CONNEXION ... the 45th Annual Drug Information Association (DIA) Meeting, ... a talk entitled "Effective Publication Practices" (Abstract number ... pharmaceutical industry five-day summit uniting professionals from all ...
... Reform should start with "evidence-based reimbursement", structuring physician ... benefit, which would improve quality and reduce the ... two cardiologists and published in Circulation: Cardiovascular ... For example, some 500,000 U.S. patients suffering from ...
... from UC San Diego just moved closer to ... from "proliferation mode" to "specialization mode." This computational ... bioengineering department could lead to new ideas for ... published in Nature Genetics , could also ...
... YDNT ) today announced that it will broadcast its ... conference call on Tuesday, April 28, 2009 at 11:00 a.m. Central ... available through InterCall at http://tinyurl.com/ydnt1QTR09 . ... available through the Company,s website, www.ydnt.com .For those ...
... and Women,s Hospital (BWH) and the Harvard-MIT Division ... way to deliver cancer drugs directly to tumors by ... pathway and deliver a higher concentration of medication to ... April 20, in an early online edition of the ...
Cached Medicine News:Health News:Subaru of America CMO Tim Mahoney and Restaurateur Stephen Starr to receive ActionAIDS' Friend for Life Award April 30 2Health News:Subaru of America CMO Tim Mahoney and Restaurateur Stephen Starr to receive ActionAIDS' Friend for Life Award April 30 3Health News:Subaru of America CMO Tim Mahoney and Restaurateur Stephen Starr to receive ActionAIDS' Friend for Life Award April 30 4Health News:Health-care reform should start with paying evidence-based financial incentives to doctors 2Health News:How cells change gears: New insights published in Nature Genetics 2Health News:How cells change gears: New insights published in Nature Genetics 3Health News:Young Innovations, Inc. Provides First Quarter Conference Call Details 2Health News:Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors 2Health News:Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors 3Health News:Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors 4
(Date:5/6/2015)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader ... at the Bank of America Merrill Lynch 2015 Health Care ... Vegas, Nevada on Wednesday, May 13, at 8 ... the presentation can be accessed via Zimmer,s Investor Relations website ... replay following the conference. About the Company Founded ...
(Date:5/6/2015)... YORK , May 6, 2015  The fairness ... or the "Company") by Alexion Pharmaceuticals, Inc. ("Alexion") is ... shareholder rights law firm, for possible breaches of fiduciary ... of Directors of GEVA for agreeing to sell the ... announced a definitive agreement for Alexion to acquire GEVA ...
(Date:5/6/2015)... 2015 China Biologic Products, Inc. (NASDAQ: CBPO, ... plasma-based biopharmaceutical company in China, today announced its unaudited ... First Quarter 2015 Financial Highlights ... increased by 25.0% to $70.4 million from $56.3 million ... profit increased by 18.9% to $45.9 million from $38.6 ...
Breaking Medicine Technology:WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2China Biologic Reports Financial Results for the First Quarter of 2015 2China Biologic Reports Financial Results for the First Quarter of 2015 3China Biologic Reports Financial Results for the First Quarter of 2015 4China Biologic Reports Financial Results for the First Quarter of 2015 5China Biologic Reports Financial Results for the First Quarter of 2015 6China Biologic Reports Financial Results for the First Quarter of 2015 7China Biologic Reports Financial Results for the First Quarter of 2015 8China Biologic Reports Financial Results for the First Quarter of 2015 9China Biologic Reports Financial Results for the First Quarter of 2015 10China Biologic Reports Financial Results for the First Quarter of 2015 11China Biologic Reports Financial Results for the First Quarter of 2015 12China Biologic Reports Financial Results for the First Quarter of 2015 13China Biologic Reports Financial Results for the First Quarter of 2015 14China Biologic Reports Financial Results for the First Quarter of 2015 15China Biologic Reports Financial Results for the First Quarter of 2015 16China Biologic Reports Financial Results for the First Quarter of 2015 17China Biologic Reports Financial Results for the First Quarter of 2015 18
... many injections, in two pivotal Phase 3 trials, ... of sustained virologic response comparable to Pegasys (peginterferon ... comparable rates of serious and/or severe adverse events ... alfa-2a -- Submission of global marketing applications planned ...
... for the treatment of type 2 diabetesHAYWARD, Calif., April ... of patient accrual to a phase 1b clinical study ... study is being conducted at multiple centers in the ... with type 2 diabetes for a period of 4 ...
Cached Medicine Technology:Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 2Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 3Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 4Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 5Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 6Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 7Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 8Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 2Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 3
... to block tear drainage through the canaliculus, synthetic ... eye symptoms:, Indicated for use in the ... eye components of various ocular surface diseases, May ... eye related complications and to enhance the retention ...
... Inserted into the punctal opening to block ... provide long-term relief of dry eye symptoms, ... of its own natural tears:, Low-profile ... Flexibility of cap design facilitates easy removal ...
... The distinctive low profile dome head combined ... patient comfort. The pointed nose design simplifies ... shelf firmly secures plug making dislocation less ... and eliminates premature plug release. SOFT PLUG ...
... Flow Controllers may be used ... too much. The tapered shaft ... vector force, keeping it snugly ... it can be monitored. Designed ...
Medicine Products: